Marianne E Pavel Selected Research

Marianne E Pavel Research Topics

Disease

17	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2005
10	Neoplasms (Cancer) 01/2021 - 01/2005
6	Carcinoid Tumor (Carcinoid) 01/2019 - 12/2011
5	Disease Progression 12/2021 - 02/2011
5	Fatigue 01/2021 - 02/2011
4	Stomatitis 01/2017 - 02/2011
3	Neuroendocrine Carcinoma 01/2021 - 04/2005
3	Diarrhea 01/2017 - 02/2011
2	Hyperglycemia 01/2021 - 02/2011
2	Infections 03/2016 - 02/2011
2	Exanthema (Rash) 12/2011 - 02/2011
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021
1	Hypercholesterolemia 01/2021
1	Nausea 01/2021
1	Adenocarcinoma 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2017
1	Flushing 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Astrocytoma (Pilocytic Astrocytoma) 01/2013
1	Tuberous Sclerosis (Bourneville's Disease) 01/2013
1	Carcinogenesis 01/2013
1	Angiomyolipoma 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 12/2012
1	Anemia 02/2011
1	Chronic Hepatitis C 01/2006
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2003
1	Acidosis 01/2003
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2003
1	Asphyxia (Suffocation) 01/2003

Drug/Important Bio-Agent (IBA)

10	Everolimus FDA Link 01/2021 - 02/2011
6	Pharmaceutical PreparationsIBA 01/2021 - 02/2011
5	Octreotide (Sandostatin)FDA LinkGeneric 12/2021 - 01/2006
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 01/2005
3	TOR Serine-Threonine KinasesIBA 01/2021 - 02/2011
3	lanreotide (Somatuline)FDA Link 01/2019 - 08/2018
3	Chromogranin AIBA 01/2019 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2018
3	Hydroxyindoleacetic AcidIBA 01/2019 - 01/2005
2	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2021 - 01/2017
2	PlatinumIBA 01/2021 - 05/2020
2	AcidsIBA 01/2019 - 08/2018
2	Interferon-alpha (Interferon Alfa)IBA 01/2006 - 01/2005
1	lutetium Lu 177 dotatateIBA 12/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	spartalizumabIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Proton Pump InhibitorsIBA 08/2018
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2017
1	GastrinsIBA 01/2017
1	Glucagon (Glukagon)FDA Link 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Protein Kinases (Protein Kinase)IBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2006
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2005
1	Interleukin-8 (Interleukin 8)IBA 04/2005
1	CytokinesIBA 04/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2005
1	angiogeninIBA 04/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2005
1	Streptozocin (Streptozotocin)FDA Link 01/2005
1	SaltsIBA 01/2003

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2005
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2005
1	Adjuvant Chemotherapy 05/2020
1	Radiotherapy 01/2017
1	Precision Medicine 11/2016
1	Prostheses and Implants (Prosthesis) 12/2012
1	Stents 12/2012
1	Biological Therapy 01/2005
1	Artificial Respiration (Mechanical Ventilation) 01/2003